Asset Management One’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.8M Buy
55,754
+8,428
+18% +$1.65M 0.03% 435
2026
Q1
$9.27M Buy
47,326
+1,997
+4% +$388K 0.03% 466
2025
Q4
$7.95M Sell
45,329
-465
-1% -$84.7K 0.02% 523
2025
Q3
$8.73M Sell
45,794
-173
-0.4% -$30.7K 0.03% 491
2025
Q2
$8.26M Buy
45,967
+1,238
+3% +$215K 0.03% 492
2025
Q1
$7.57M Sell
44,729
-151
-0.3% -$24.8K 0.03% 492
2024
Q4
$6.85M Buy
44,880
+545
+1% +$84.8K 0.02% 528
2024
Q3
$6.88M Buy
44,335
+3,288
+8% +$491K 0.02% 522
2024
Q2
$5.62M Sell
41,047
-3,388
-8% -$464K 0.02% 548
2024
Q1
$5.91M Sell
44,435
-1,607
-3% -$209K 0.02% 552
2023
Q4
$6.34M Sell
46,042
-1,112
-2% -$146K 0.03% 531
2023
Q3
$5.75M Buy
47,154
+3,057
+7% +$407K 0.03% 541
2023
Q2
$6.2M Sell
44,097
-2,972
-6% -$410K 0.03% 527
2023
Q1
$6.66M Sell
47,069
-100
-0.2% -$14.3K 0.03% 501
2022
Q4
$7.4M Sell
47,169
-1,635
-3% -$235K 0.04% 465
2022
Q3
$5.99M Sell
48,804
-2,097
-4% -$276K 0.03% 498
2022
Q2
$6.77M Sell
50,901
-3,080
-6% -$420K 0.03% 497
2022
Q1
$7.39M Sell
53,981
-8,319
-13% -$1.16M 0.03% 534
2021
Q4
$10.6M Sell
62,300
-5,886
-9% -$896K 0.04% 469
2021
Q3
$9.91M Buy
68,186
+102
+0.1% +$14.9K 0.04% 476
2021
Q2
$8.98M Sell
68,084
-1,475
-2% -$193K 0.03% 513
2021
Q1
$8.93M Buy
69,559
+439
+0.6% +$54.1K 0.04% 504
2020
Q4
$8.19M Sell
69,120
-161
-0.2% -$19.6K 0.03% 497
2020
Q3
$7.93M Sell
69,281
-2,268
-3% -$268K 0.04% 455
2020
Q2
$8.15M Sell
71,549
-12,938
-15% -$1.37M 0.04% 426
2020
Q1
$6.79M Sell
84,487
-7,549
-8% -$782K 0.04% 417
2019
Q4
$9.83M Buy
92,036
+17,612
+24% +$1.84M 0.04% 418
2019
Q3
$7.96M Buy
74,424
+732
+1% +$75.1K 0.04% 467
2019
Q2
$7.5M Sell
73,692
-1,648
-2% -$158K 0.04% 486
2019
Q1
$6.77M Sell
75,340
-160,483
-68% -$13.9M 0.04% 482
2018
Q4
$19.6M Buy
235,823
+1,641
+0.7% +$154K 0.05% 408
2018
Q3
$25.3M Buy
234,182
+2,877
+1% +$316K 0.05% 391
2018
Q2
$25.4M Sell
231,305
-4,917
-2% -$512K 0.06% 377
2018
Q1
$23.7M Buy
236,222
+6,153
+3% +$630K 0.05% 385
2017
Q4
$22.7M Sell
230,069
-41,578
-15% -$3.94M 0.05% 401
2017
Q3
$25.3M Buy
271,647
+51,964
+24% +$5.52M 0.06% 349
2017
Q2
$24.4M Sell
219,683
-4,634
-2% -$490K 0.06% 341
2017
Q1
$22M Sell
224,317
-16,041
-7% -$1.53M 0.06% 359
2016
Q4
$22.1M Buy
240,358
+226,737
+1,665% +$19.5M 0.06% 359
2016
Q3
$1.14M Buy
13,621
+658
+5% +$55.3K 0.02% 806
2016
Q2
$1.04M Sell
12,963
-2,623
-17% -$200K 0.02% 828
2016
Q1
$1.12M Sell
15,586
-42,820
-73% -$2.87M 0.02% 830
2015
Q4
$4.17M Sell
58,406
-26,320
-31% -$1.77M 0.06% 363
2015
Q3
$5.2M Buy
84,726
+60,040
+243% +$4.2M 0.08% 310
2015
Q2
$1.77M Buy
24,686
+969
+4% +$71.5K 0.02% 704
2015
Q1
$1.83M Sell
23,717
-6,442
-21% -$461K 0.02% 714
2014
Q4
$2.03M Sell
30,159
-1,712
-5% -$108K 0.03% 678
2014
Q3
$1.95M Buy
31,871
+15,370
+93% +$947K 0.03% 616
2014
Q2
$970K Sell
16,501
-4,970
-23% -$291K 0.01% 775
2014
Q1
$1.24M Buy
21,471
+4,970
+30% +$266K 0.02% 646
2013
Q4
$891K Sell
16,501
-5,525
-25% -$328K 0.01% 775
2013
Q3
$1.36M Buy
22,026
+2,142
+11% +$128K 0.02% 641
2013
Q2
$1.22M Buy
+19,884
New +$1.18M 0.02% 624

Other funds holding DGX

Asset Management One's DGX Position: Q2 2026 in Review

Asset Management One increased its Quest Diagnostics (DGX) stake by 18% in Q2 2026, buying an estimated $1.65M and bringing the position to 55,754 shares worth $11.8M. The position accounts for 0.03% of the portfolio, ranked #435.

Asset Management One first reported a position in DGX in Q2 2013 and has held it in 53 quarters since. The position peaked at $25.4M in Q2 2018. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Asset Management One held 55,754 shares of Quest Diagnostics worth $11.8M as of Q2 2026.
  • Asset Management One bought 8,428 Quest Diagnostics shares in Q2 2026, an estimated $1.65M.
  • Quest Diagnostics made up 0.03% of Asset Management One's portfolio in Q2 2026, its #435 holding.
  • Asset Management One first reported a position in Quest Diagnostics in Q2 2013 and has held it in 53 quarters since.
  • Asset Management One's Quest Diagnostics position peaked at $25.4M in Q2 2018.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Asset Management One's 13F filing for Q2 2026, filed 28 Jul 2026.